Equities Research Analysts’ downgrades for Thursday, August 24th:

BHP Billiton PLC (NYSE:BBL) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.

BioLineRx (NASDAQ:BLRX) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

BofI Holding (NASDAQ:BOFI) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.

CAI International (NYSE:CAI) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

Meta Financial Group (NASDAQ:CASH) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.

Corium International (NASDAQ:CORI) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

The Dixie Group (NASDAQ:DXYN) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

FelCor Lodging Trust (NYSE:FCH) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.

Fabrinet (NYSE:FN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Fabrinet provides precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers and sensors. The Company offers a broad range of advanced optical capabilities across the entire manufacturing process, including process engineering, design for manufacturability, supply chain management, manufacturing, final assembly and test. Fabrinet manufactures, assembles, and tests products for customers at its main manufacturing facilities in Bangkok, Thailand. The Company designs and manufactures its own bulk optical materials and components at its facilities in Fuzhou, the People’s Republic of China, and New Jersey, USA. “

FENNER (NASDAQ:FNERF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Fenner plc is a polymer technology company, which manufactures and distributes conveyor belting and reinforced precision polymer products. It operates through the Engineered Conveyor Solutions and Advanced Engineered Products segments. Engineered Conveyor Solutions segment manufactures rubber ply, solid woven and steel cord conveyor belting for mining, power generation and industrial applications. Advanced Engineered Products segment manufactures precision polymer products including precision drives for computer peripherals, copiers and ATMs; problem solving power transmission and motion transfer components; silicone and complex hoses; seals and sealing solutions for the fluid power and oil and gas industries; technical textiles for medical and industrial applications and silicone based products and fluropolymer components for fluid and gas handling. Fenner plc is headquartered in Hessle, the United Kingdom. “

Glanbia Plc ADR (OTC:GLAPY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Glanbia Plc engages in the manufacture and distribution of dairy and nutritional food products. Its operating segments include Glanbia Performance Nutrition, Global Ingredients, Dairy Ireland and Joint Ventures and Associates. Glanbia Performance Nutrition segment comprises of performance nutrition products under the Optimum Nutrition, BSN, Isopure, Nutramino and ABB brands. Global Ingredients segment includes American-style cheddar cheese, micro-nutrient premixes and dairy and non-dairy nutritional solutions. Dairy Ireland segment consists of consumer products and agribusiness. Joint Ventures and Associates segment covers Glanbia Ingredients Ireland, Glanbia Cheese and Southwest Cheese. Glanbia Plc is headquartered in Kilkenny, Ireland. “

General Moly (NYSEMKT:GMO) (TSE:GMO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “General Moly is a U.S.-based molybdenum mineral exploration and development company listed on the American Stock Exchange and the Toronto Stock Exchange under the symbol GMO. Their primary asset, their interest in the Mt. Hope project located in central Nevada, is considered one of the world’s largest and highest grade molybdenum deposits. Combined with their second molybdenum property, the Hall-Tonopah project which is also located in central Nevada. Their goal is to become the largest primary molybdenum producer by the middle of the next decade. “

Genius Brands International (OTCMKTS:GNUS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Genius Brands International, Inc. is a multimedia content and brand management company. It provides entertaining and enriching content and products for toddlers to Tweens. The Company’s portfolio includes Baby Genius, Secret Lab, Kid Genius, Mighty 7, Stan Lee Comics and Secret Millionaires Club, Llama Llama and a tween adventure series, Space Pop. Genius Brands International, Inc. is headquartered in Beverly Hills, USA. “

GRAFTON GROUP UT(1 (NASDAQ:GROUF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Grafton Group plc manufactures and retails building supplies. The Company operates the Plumbase, Buildbase, Jackson, MacNaughton Blair, Chadwicks and Woodies retail chains as well as produces dry mortar. It operates primarily in Britain, Ireland, the Netherlands and Belgium. Grafton Group plc is headquartered in Dublin, Ireland. “

Halozyme Therapeutics (NASDAQ:HALO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company’s broad product development portfolio, including expected near- and long-term product offerings, is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company’s initial products are being developed to offer safer and purer alternatives toexisting slaughterhouse derived extracts that carry risks of pathogen contamination, immunogenicity, and toxicity. The commercialization of Halozyme’s highly versatile enzyme technology within proven markets will enable the company to positively impact the quality of medicine. “

HTG Molecular Diagnostics (NASDAQ:HTGM) was downgraded by analysts at ValuEngine from a sell rating to a strong sell rating.

Iveda Solutions (OTCBB:IVDA) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

Klondex Mines (NYSEMKT:KLDX) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

Lazard (NYSE:LAZ) was downgraded by analysts at ValuEngine from a strong-buy rating to a buy rating.

Methode Electronics (NYSE:MEI) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

Spring Bank Pharmaceuticals (NASDAQ:SBPH) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

Wolverine World Wide (NYSE:WWW) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.